First solid state alkaline-earth complexes of monensic acid A (MonH): crystal structure of [M(Mon)2(H (2)O)2] (M = Mg, Ca), spectral properties and cytotoxicity against aerobic Gram-positive bacteria.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 19768636)

Published in Biometals on September 21, 2009

Authors

Ivayla N Pantcheva1, Rumyana Zhorova, Mariana Mitewa, Svetlana Simova, Heike Mayer-Figge, William S Sheldrick

Author Affiliations

1: Laboratory on Biocoordination and Bioanalytical Chemistry, Department of Analytical Chemistry, Faculty of Chemistry, Sofia University, 1164 Sofia, Bulgaria. ipancheva@chem.uni-sofia.bg

Articles by these authors

Bioactive constituents of brazilian red propolis. Evid Based Complement Alternat Med (2006) 1.56

Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties. J Med Chem (2010) 1.00

Comparative in vitro evaluation of N-heterocyclic carbene gold(I) complexes of the benzimidazolylidene type. J Med Chem (2011) 0.91

Synthesis, structure and antimicrobial activity of manganese(II) and cobalt(II) complexes of the polyether ionophore antibiotic Sodium Monensin A. J Inorg Biochem (2007) 0.88

Synthesis, biological activity, and structure-activity relationships for potent cytotoxic rhodium(III) polypyridyl complexes. J Med Chem (2008) 0.87

A gold(I) phosphine complex containing a naphthalimide ligand functions as a TrxR inhibiting antiproliferative agent and angiogenesis inhibitor. J Med Chem (2009) 0.87

Structure-activity relationships and DNA binding properties of apoptosis inducing cytotoxic rhodium(III) polypyridyl complexes containing the cyclic thioether [9]aneS(3). J Inorg Biochem (2009) 0.86

[N,N'-Bis(salicylidene)-1,2-phenylenediamine]metal complexes with cell death promoting properties. J Biol Inorg Chem (2009) 0.85

Carbaboranes as pharmacophores: similarities and differences between aspirin and asborin. Eur J Med Chem (2011) 0.84

Dinuclear organoiridium(III) mono- and bis-intercalators with rigid bridging ligands: synthesis, cytotoxicity and DNA binding. J Inorg Biochem (2009) 0.82

Modulation of the biological properties of aspirin by formation of a bioorganometallic derivative. Angew Chem Int Ed Engl (2009) 0.81

On the biological properties of alkynyl phosphine gold(I) complexes. Angew Chem Int Ed Engl (2012) 0.81

Crystal structure and properties of the copper(II) complex of sodium monensin A. J Inorg Biochem (2009) 0.81

Identification of (eta6-arene)ruthenium(II) protein binding sites in E. coli cells by combined multidimensional liquid chromatography and ESI tandem mass spectrometry: specific binding of [(eta6-p-cymene)RuCl2 (DMSO)] to stress-regulated proteins and to helicases. J Biol Inorg Chem (2007) 0.81

Spectroscopic and structural elucidation of 4-dimethylaminopyridine and its hydrogensquarate. Spectrochim Acta A Mol Biomol Spectrosc (2008) 0.81

2-amino-4-nitroaniline, a known compound with unexpected properties. J Phys Chem A (2007) 0.81

The tetraethylammonium salt of monensic acid-An antidote for subacute cadmium intoxication: a study using an ICR mouse model. J Trace Elem Med Biol (2012) 0.80

Characterisation of cisplatin coordination sites in cellular Escherichia coli DNA-binding proteins by combined biphasic liquid chromatography and ESI tandem mass spectrometry. J Biol Inorg Chem (2007) 0.80

First divalent metal complexes of the polyether ionophore Monensin A: X-Ray structures of [Co(Mon)2(H2O)2] and [Mn(Mon)2(H2O)2] and their bactericidal properties. Curr Drug Discov Technol (2008) 0.80

Evaluation of arene ruthenium(II) N-heterocyclic carbene complexes as organometallics interacting with thiol and selenol containing biomolecules. Dalton Trans (2012) 0.80

Cobalt-induced changes in the spleen of mice from different stages of development. J Toxicol Environ Health A (2012) 0.80

Highly cytotoxic substitutionally inert rhodium(III) tris(chelate) complexes: DNA binding modes and biological impact on human cancer cells. J Inorg Biochem (2011) 0.79

Gold(I) N-heterocyclic carbene complexes with naphthalimide ligands as combined thioredoxin reductase inhibitors and DNA intercalators. ChemMedChem (2014) 0.79

The influence of methionine-containing peptides on the reaction of carboplatin with 5'-guanosine monophosphate: a comparison with cisplatin. J Inorg Biochem (2003) 0.79

Cisplatin mediates selective downstream hydrolytic cleavage of Met-(Gly)(n)-His segments (n=1,2) in methionine- and histidine-containing peptides: the role of ammine loss trans to the initial Pt-S(Met) anchor in facilitating amide hydrolysis. J Inorg Biochem (2006) 0.79

Cytotoxicity and cellular impact of dinuclear organoiridium DNA intercalators and nucleases with long rigid bridging ligands. Dalton Trans (2012) 0.79

Cell-selective, apoptosis-inducing rhodium(III) crown thiaether complexes. ChemMedChem (2010) 0.78

Antileukemic activity and cellular effects of rhodium(III) crown thiaether complexes. Biometals (2011) 0.78

Cellular selectivity and biological impact of cytotoxic rhodium(III) and iridium(III) complexes containing methyl-substituted phenanthroline ligands. ChemMedChem (2011) 0.78

A simple route for renewable nano-sized arjunolic and asiatic acids and self-assembly of arjuna-bromolactone. Beilstein J Org Chem (2008) 0.78

Cisplatin-mediated selective hydrolytic cleavage of methionine-containing peptides with neighboring serine or histidine residues. J Inorg Biochem (2004) 0.77

Synthesis and cellular impact of diene-ruthenium(II) complexes: a new class of organoruthenium anticancer agents. J Inorg Biochem (2011) 0.77

Cytotoxic rhodium(III) and iridium(III) polypyridyl complexes: structure-activity relationships, antileukemic activity, and apoptosis induction. ChemMedChem (2009) 0.77

Cellular impact and selectivity of half-sandwich organorhodium(III) anticancer complexes and their organoiridium(III) and trichloridorhodium(III) counterparts. J Biol Inorg Chem (2012) 0.76

Characterisation of cisplatin binding sites in human serum proteins using hyphenated multidimensional liquid chromatography and ESI tandem mass spectrometry. ChemMedChem (2008) 0.76

Cd(II) and Pb(II) complexes of the polyether ionophorous antibiotic salinomycin. Chem Cent J (2011) 0.75

Acute toxicity of vipoxin and its components: is the acidic component an "inhibitor" of PLA2 toxicity? Interdiscip Toxicol (2012) 0.75

Synthesis, spectroscopic and structural elucidation of tyrosinamide hydrogensquarate monohydrate. Amino Acids (2008) 0.75

Effects of cadmium and monensin on spleen of mice, subjected to subacute cadmium intoxication. J Toxicol Environ Health A (2013) 0.75

Water-soluble phosphines. 17.(1) novel water-soluble secondary and tertiary phosphines with disulfonated 1,1'-biphenyl backbones and dibenzophosphole moieties. Inorg Chem (2002) 0.75

On the origin of the color in the solid state. Crystal structure and optical and magnetic properties of 4-cyanopyridinium hydrogensquarate monohydrate. J Phys Chem A (2008) 0.75

N,N-Diethyl-N'-[(E)-4-pyridylmethylene]benzene-1,4-diamine: a combined X-ray and density functional theory study. Acta Crystallogr C (2009) 0.75

P.E.HSQC: a simple experiment for simultaneous and sign-sensitive measurement of (1JCH+DCH) and (2JHH+DHH) couplings. J Magn Reson (2007) 0.75

Variable coordination mode of chloranilic acid. Synthesis, structure, and electrochemical properties of some osmium complexes. Inorg Chem (2005) 0.75

Synthesis, spectroscopic and structural elucidation of sympathomimetic amine, tyraminium dihydrogenphosphate. Amino Acids (2008) 0.75

The biological activity of Zeise's salt and its derivatives. Angew Chem Int Ed Engl (2015) 0.75

Cell response of Escherichia coli to cisplatin-induced stress. Proteomics (2011) 0.75

Synthesis, characterization, and in vitro antiproliferative activity of [salophene]platinum(II) complexes. ChemMedChem (2014) 0.75

Atomic absorption spectrometric determination of the iridium content in tumor cells exposed to an iridium metallodrug. J Pharm Biomed Anal (2008) 0.75

Kinetics of degradation of dipalmitoylphosphatidylcholine (DPPC) bilayers as a result of vipoxin phospholipase A2 activity: an atomic force microscopy (AFM) approach. Biochim Biophys Acta (2010) 0.75

L-Leucinamide hydrogensquarate: spectroscopic and structural elucidation. Amino Acids (2008) 0.75

Configuration verification via RDCs on the example of a tetra-substituted pyrrolidine ring. Magn Reson Chem (2012) 0.75

L-Argininamidium bis(hydrogensquarate). Acta Crystallogr C (2006) 0.75

Determination of the diastereoisomeric purity of D,L- and meso-HM-PAO by 13C-NMR spectroscopy. Eur J Med Chem (2003) 0.75

Crystal structure and spectroscopic elucidation of 3-phenylpyridinium hydrogensquarate. Spectrochim Acta A Mol Biomol Spectrosc (2010) 0.75

Correlations between lithium local structure and electrochemistry of layered LiCo(1-2x)Ni(x)Mn(x)O2 oxides: 7Li MAS NMR and EPR studies. Phys Chem Chem Phys (2014) 0.75

Sulfur-substituted naphthalimides as photoactivatable anticancer agents: DNA interaction, fluorescence imaging, and phototoxic effects in cultured tumor cells. Bioorg Med Chem (2008) 0.75

Tyrammonium 4-nitrophthalate dihydrate: structural and spectroscopic elucidation. Amino Acids (2008) 0.75

Crystal structures and spectroscopic properties of ester amide and diamide of squaric acid with prolinamide. Spectrochim Acta A Mol Biomol Spectrosc (2008) 0.75

Four cycloalkanespiro-4'-imidazolidine-2',5'-dithiones. Acta Crystallogr C (2006) 0.75

Self-assembly of novel molecular complexes of 1,10-phenanthroline and 5-amino-1,10-phenanthroline and evaluation of their in vitro antitumour activity. Eur J Med Chem (2011) 0.75

Synthesis, cellular uptake and structure-activity relationships for potent cytotoxic trichloridoiridium(III) polypyridyl complexes. J Inorg Biochem (2008) 0.75